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Summary The clonal rat rhabdomyosarcoma cell line BA-HAN-IC was tested for its susceptibility to
differentiation induction with different polar compounds. This cell line is composed of proliferating mono-
nuclear tumour cells, some of which spontaneously fuse to form terminally differentiated postmitotic myotube-
like giant cells. Exposure of BA-HAN-IC cells to dimethylsulphoxide (DMSO), hexamethylene bisacetamide
(HMBA), sodium butyrate (NaBut) and N-monomethylformamide (NMF) resulted in a significant inhibition
of proliferation (P<0.001) and in a simultaneous increase in differentiation. The response was most pro-
nounced after exposure to NMF as evidenced by a marked increase in the creatine kinase activity used as a
biochemical marker of differentiation (P<0.05) and the number of terminally differentiated myotube-like
giant cells (P<0.001). Furthermore, about 5% of the mononuclear cells exhibited thick and thin myofilaments
which were never observed in the mononuclear cells of the control. In contrast, the effects of DMSO, HMBA
and NaBut were exclusively confined to a significant increase in biochemical differentiation (P<0.05), whereas
no increase in morphological differentiation was observed and the number of myotube-like giant cells even
significantly (P<0.001) decreased. This heterogeneous response to differentiation induction with different
polar compounds probably indicates different mechanisms of action and suggests that the induction of
biochemical differentiation might be independently regulated from events leading to cell fusion and terminal
differentiation.
Cancer cells have not necessarily lost all the genes that
control differentiation and proliferation. Thus, in many can-
cers at least some of the tumour cells spontaneously exhibit
abortive attempts at normal differentiation (Pierce, 1974).
Furthermore, induction of differentiation has been success-
fully achieved in several in vitro systems (for review see
Freshney, 1985) indicating that the malignant phenotype
does not necessarily represent an irreversible state and that
the conversion ofmalignant cells to a more benign phenotype
through differentiation induction may become an alternative
therapeutic approach (Metcalf, 1983; Spremulli & Dexter,
1984; Freshney, 1985; Sartorelli, 1985; Sachs, 1987). We
recently described the effects of retinoic acid on the diff-
erentiation and proliferation of the clonal rat rhabdomyosar-
coma cell line BA-HAN-IC (Gabbert et al., 1988a). This cell
line closely imitates embryonic rhabdomyogenesis (Gerharz
et al., 1988) and is composed of myogenically committed but
morphologically undifferentiated mononuclear cells, some of
which spontaneously fuse to form multinuclear myotube-like
giant cells with ultrastructural features of rhabdomyogenic
differentiation. These myotube-like giant cells were shown to
have irreversibly withdrawn from the mitotic cycle represen-
ting terminally differentiated postmitotic tumour cells (Gab-
bert et al., 1988b). We could further demonstrate that the
protooncogenes fos and rqfare involved in the differentiation
induction of BA-HAN-IC tumour cells after exposure to
retinoic acid (Doehmer et al., 1989). It is not yet known,
however, whether differentiation inducers exclusively act at
the nuclear site affecting protooncogene expression. There-
fore, we were looking for other effective inducers of diff-
erentiation, possibly having modes of action other than those
of retinoic acid. Polar compounds such as dimethylsulphox-
ide (DMSO) (Friend et al., 1971; Collins et al., 1978; Tarella
et al., 1982; Tsao et al., 1982), hexamethylene bisacetamide
(HMBA) (Reuben et al., 1976; Ramsay et al., 1986; Mans-
field et al., 1988; Snyder et al., 1988), sodium butyrate (Na-
But) (Prasad & Sinha, 1976; Dexter et al., 1981; Augeron &
Laboisse, 1984; Nordenberg et al., 1987; Lee et al., 1988),
and N-monomethylformamide (NMF) (Dexter et al., 1982;
Dibner et al., 1985; Cordeiro & Savarese, 1986; Iwakawa et
al., 1987) are known to be potent inducers of differentiation
in non-myogenic cell lines. The effects of these polar com-
pounds on the differentiation of myogenic tumours, however,
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have only been sporadically described (Dexter 1977; Garvin
et al., 1986). Furthermore, DMSO, HMBA and NaBut have
been reported to inhibit terminal differentiation and myo-
tube-formation in non-tumorigenic myoblast cell lines (Mir-
anda et al., 1978; Blau & Epstein, 1979; Fiszman et al., 1980;
Endo & Nadal-Ginard, 1987). Therefore, we investigated the
susceptibility of the rhabdomyosarcoma cell line BA-HAN-
IC to differentiation induction with polar compounds. The
availability of quite a panel of differentiation inducers diff-
ering in their chemical characteristics, mode of action and
effects on biochemical and morphological aspects of differ-
entiation should facilitate further studies on the regulatory
events taking place during differentiation induction in our
rhabdomyosarcoma cell line BA-HAN-IC.
Material and methods
Cells and culture
The clonal cell line BA-HAN-IC used in this study was
derived in our laboratory from a dimethylbenzanthracene-
induced rhabdomyosarcoma in rat (Gerharz et al., 1988). The
clonal origin of this cell line had been confirmed by repeated
recloning procedures. Investigations were performed with cul-
tures between passage nos 10 and 30. The standard growth
medium was Dulbecco's modified Eagle's medium (DMEM,
Gibco Europe, FRG), supplemented with 10% heat-inact-
ivated fetal calf serum, penicillin and streptomycin. The same
batch of FCS was used for all experiments to eliminate any
possible changes in quality. Unless otherwise noted, cultures
were refed every 4 days. The tumour cells were cultured in 25
and 80cm2 Nunclon-flasks (Gibco Europe, FRG) and incu-
bated in an atmosphere with 5% CO2 at 37°C. The cells were
detached from the surface of the tissue culture flasks by
exposure to 0.05% EDTA. Cell counts were performed with
a Neubauer haemocytometer chamber.
Induction ofdifferentiation
Stock solutions of DMSO (Sigma, FRG), HMBA (Sigma,
FRG), NaBut (Sigma, FRG) and NMF (Sigma, FRG) were
prepared and sterilised by filtration. Preliminary experiments
were performed to determine the range of concentration for
each differentiation inducer, which permitted tumour cell
proliferation without non-specific cytotoxic effects as evi-
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denced by the trypan blue exclusion test. To this end, 25 cm2
culture flasks were each seeded with 1 x 106 cells. The effects
of different concentrations of DMSO (0.2%; 1%; 2%; 5%),
HMBA (0.5 mM; 1 mM; 5 mM; 10 mM), NaBut (0.2 mM;
1 mM; 2 mM; 10 mM), and NMF (0.1%; 0.5%; 1%; 5%) were
evaluated in four replicate culture flasks per concentration.
After exposure for 3 days, the number of tumour cells was
determined with the Neubauer haemocytometer chamber.
Afterwards, the creatine kinase activity was determined as
described below.
The results of these preliminary experiments are summar-
ised in Table I, indicating a clear dose-response relationship.
For further experiments on differentiation induction, concen-
trations of 2% (v/v) DMSO, 5 mM HMBA, 2 mM NaBut,
and 1% (v/v) NMF were chosen, permitting tumour cell
proliferation without non-specific cytotoxic effects and yield-
ing a maximum of creatine kinase activity.
Assessment of differentiation in vitro
In vitro morphology For transmission electron microscopy,
the tumour cells were seeded on glass cover slips. After
incubation for 3 days, the tumour cells were fixed in situ by
exposure to a 2.5% sodium cacodylate-buffered glutaral-
dehyde solution (0.1 mol; pH 7.4) and postfixed in a 1%
sodium cacodylate-buffered osmium tetroxyde solution
(0.1 mol; pH 7.4) before Epon embedding. Thin sections were
contrasted with uranyl acetate and lead citrate. Electron
photomicrographs were taken with an EM 410 Philips trans-
mission electron microscope. Phase contrast photomicrog-
raphs were taken with a Leitz Labovert inverted microscope.
Creatine kinase activity Twenty-five cm2 culture flasks were
each seeded with 4 x 105 cells and 20 replicate culture flasks
were each exposed to growth medium containing 2% (v/v)
DMSO, 5 mM HMBA, 2mM NaBut or 1% (v/v) NMF,
respectively. As control 20 replicate culture flasks received
inocula of 4 x 105 cells each in standard growth medium. In
each experiment cells from five culture flasks were harvested
separately every day for 4 days. The number of cells har-
vested was determined with the Neubauer haemocytometer
chamber. Afterwards, the cells were disrupted by sonication
and the total creatine kinase activity, which was used as a
biochemical marker of differentiation (Delaporte et al., 1986;
Garvin et al., 1986), was determined on an Olympus AU
5031 analyser using the CK-test (NAC activated) from
Merck (Darmstadt, FRG). The basic creatine kinase activity
Table I Growth behaviour and creatine kinase activity of BA-HAN-
IC tumour cells after exposure to different concentrations of DMSO,
HMBA, NaBut and NMF for 3 days
Creatine kinase
Cell number activity (mU 106 cells)
Control 9.9 x 106 + 0.6 x 106 18 ± 3
DMSO 0.2% 6.5 x 106+0.6 x 106* 16± 5
1% 5.2 x 106 + 0.5 x106* 30 ± 14
2% 2.2 x 106 + 0.2 x106* 56 ± 23*
5% 0.1x106 + 0.3 x 105* 232 ± 71*
HMBAO.5mM 8.6 x 106 + 0.8 x 106 20 ± 5
1mM 8.1 x106 +0.3 xl06* 21 ± 6
5mM 2.8x 106+0.3x 106* 96± 6*
10mM 1.1 x 106+0.2x 106* 142±29*
NaBut0.2mM 10.5x106+1.0x106 12± 4
1mM 4.4 x 106± 0.6 x 106* 85 ± 10*
2mM 2.9x106+0.4x106* 222±50*
10mM 0.4x 106+0.2x 105* 726±41*
NMF 0.1% 9.9 x 106+0.8 x 106 13± 6
0.5% 9.3 x 106+0.3 x106 12± 5
1% 6.0x 106±0.3x 106* 37± 6*
5% cytotoxic
The initial inoculum per culture flask was I x 106 cells. Each value
represents the mean ± standard deviation of 4 replicate experiments.
*Statisticallysignificant difference from thecontrol (p <0.05; Wilcoxon
test for unpaired samples).
of the tumour cells (time point: 0) was determined separately
in five samples. The data were statistically analysed by the
Wilcoxon test for unpaired samples.
Fusion assay A total of 3 x 105 tumour cells each were
seeded into 25 cm2 culture flasks. On the bottom of these
culture flasks four arbitrarily located fields had been marked.
The area marked out by these four fields was 1/32 the growth
area of the culture flask. After 24 h the standard growth
medium was completely substituted by the differentiation
inducing media. The number of myotube-like giant cells in
the marked fields was counted by phase contrast microscopy
at intervals of 24 h. Cells that contained three or more nuclei
were classified as myotube-like giant cells. The effects of 2%
(v/v) DMSO, 5 mM HMBA, 2 mM NaBut or 1% (v/v) NMF
were evaluated in five replicate culture flasks each. As con-
trol, the frequency ofmyotube-like giant cells was determined
in five culture flasks each with standard growth medium. At
the end of the observation period of 120 h, the total number
of tumour cells was determined in each culture flask. The
relative frequency of myotube-like giant cells, i.e. the ratio
between the number of myotube-like giant cells (in 1/32 the
growth area of the culture flask) and the total number of
cells per culture flask, was calculated. This ratio was then
analysed by an analysis of variance with two independent
factors.
Assessment ofgrowth properties in vitro
Growth rate The data describing the proliferation of tumour
cells in standard growth medium and after exposure to polar
compounds were derived from the experiments performed to
determine the creatine kinase activity. Twenty replicate cul-
ture flasks were each exposed to growth medium containing
2% (v/v) DMSO, 5 mM HMBA, 2 mM NaBut or 1% (v/v)
NMF, respectively. As control, 20 replicate culture flasks
were exposed to standard growth medium. Each culture flask
was seeded with 4 x 105 cells. In each experiment, cells from
five culture flasks were harvested separately for 4 days. The
number of cells harvested was determined with the Neubauer
haemocytometer chamber. The data were statistically ana-
lysed by an analysis of variance with two independent fac-
tors.
Plating efficiency Tumour cells (10 cells and one cell per
microwell, respectively) were seeded on to triplicate 96-
microwell plates (Gibco Europe, FRG) containing differen-
tiation inducing media and standard growth medium. After
an incubation time of 2 weeks without refeeding, the plating
efficiency was determined by counting the number of mic-
rowells with colonies and relating these numbers to the cont-
rol.
Results
Assessment ofdifferentiation
In vitro morphology After exposure to DMSO, HMBA and
NaBut for 3 days, the mononuclear tumour cells of BA-
HAN-IC were larger, more flattened and stellate-shaped
(Figure lb) when compared to the control (Figure la). In
contrast, the mononuclear cells were more elongated and
spindle-shaped after exposure to NMF (Figure 1c) for 3
days. Transmission electron microscopy showed that about
5% of the mononuclear tumour cells exposed to NMF exhi-
bited irregular bundles of thin (6-8 nm in diameter) and
thick (12-15 nm in diameter) myofilaments (Figure le).
These morphological features of rhabdomyogenic
differentiation had never been observed in the mononuclear
counterparts under standard growth conditions (Figure 1d)
or after exposure to DMSO, HMBA and NaBut. The ultra-
structural characteristics of the myotube-like giant cells
observed after exposure to NMF, DMSO, HMBA and
NaBut did not differ from those of their multinuclear580 C.D. GERHARZ et al.
Figure 1 Morphology of BA-HAN-IC tumour cells before and after differentiation induction: (a) small spindle-shaped mono-
nuclear cells intermingled with few myotube-like giant cells under standard growth conditions as opposed to the larger, more
flattened cells after exposure to NaBut (b) and the markedly elongated mononuclear cells after exposure to NMF (c). Electron
microscopic detail of a mononuclear tumour cell in standard growth medium (d) lacking morphological features of rhab-
domyogenic differentiation. Mononuclear tumour cell after exposure to NMF (e) exhibiting numerous irregular bundles of thick
and thin myofilaments (star and inset). Arrows: myotube-like giant cells. a, b, c, bar= 1I00Jm; d, e, bar= 2gm; inset,
bar = 0.5 JLm.
counterparts under standard growth conditions (Gerharz et
al., 1988). Non-specific cytotoxic effects were excluded by the
trypan blue exclusion test and by transmission electron mic-
roscopy.
Creatine kinase activity There was a statistically significant
increase (P<0.05) in creatine kinase activity after exposure
to polar compounds for 48 h when compared to the control
(21 ± 4 mU per 106 cells). This increase in biochemical differ-
entiation, however, proved to be reversible and the creatine
kinase activity markedly decreased during the following days.
After 120 h, only tumour cells exposed to NaBut (Figure 5)
still exhibited a significantly (P<0.05) elevated level of crea-
tine kinase activity whereas the creatine kinase activity of
cells exposed to NMF (Figure 3) and HMBA (Figure 4) did
not differ significantly from the control. Tumour cells ex-
posed to DMSO (Figure 2) for 120 h even showed a statis-
tically significant (P<0.05) decrease in creatine kinase activ-
ity.
Fusion assay The absolute number of myotube-like giant
cells in cultures exposed to polar compounds for up to 96 h
did not significantly differ from the control. Exposure to
NMF for 120 h resulted in a marked increase in the absolute
number of myotube-like giant cells. Because the fusion rate is
cell density-dependent, the possibility had to be excluded that
the increased number of myotube-like giant cells was only
caused by a higher cell density in those cultures exposed to
NMF. The relative frequency therefore of myotube-like giant
cells, i.e. the ratio between the number of myotube-like giant
cells (in 1/32 of the growth area of the culture flasks) and the
total number of tumour cells per culture flask was calculated.
For this ratio, a statistically significant increase (P<0.001)
was evident after 120 h.DIFFERENTIATION INDUCTION WITH POLAR COMPOUNDS 581
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Figure 2 Growth curves and creatine kinase activity of BA-
HAN-IC tumour cells after exposure to DMSO. Each value
represents the mean ± standard deviation of five replicate experi-
ments. The creatine kinase activity is shown as a percentage of
the control. 48 h and 120 h after exposure to DMSO, the creatine
kinase activity is significantly different from the control (P<0.05;
Wilcoxon test for unpaired samples). The difference between the
growth curves is statistically significant (P<0.001; analysis of
variance with two independent factors). ck, creatine kinase
activity; tD, mean doubling time; nconrol, cell number in standard
growth medium; nDMSO, cell number in growth medium supp-
lemented with DMSO.
In contrast, the absolute number of myotube-like giant
cells in control cultures markedly exceeded the number of
myotube-like giant cells in cultures exposed to DMSO,
HMBA and NaBut after an incubation period for 120 h. The
calculation of the relative frequency of myotube-like giant
cells showed a statistically significant (P<0.001) decrease.
(See Table II.)
Assessment ofproliferation
Growth rate Under the conditions of our experiments, expo-
sure to polar compounds always resulted in a statistically
significant (P<0.001) inhibition of proliferation being most
pronounced after 48 h. Detrimental effects of the polar com-
pounds on cell viability were excluded by the trypan blue
exclusion test. After 48 h, the proliferation in cultures ex-
posed to polar compounds markedly accelerated. The initial
growth inhibition observed after exposure to NMF was com-
pensated for during the following days and after 120h in
culture, the cell density did not significantly differ between
the control cultures and NMF-exposed cultures (Figure 3). In
contrast, there was still a significantly lower cell density after
120h(P<0.001) in cultures exposed to DMSO (Figure 2),
HMBA (Figure 4) and NaBut (Figure 5).
Plating efficiency Exposure to DMSO, HMBA, NaBut and
NMF reduced the plating efficiency of BA-HAN-IC tumour
cells rather heterogeneously. HMBA proved to be most effec-
tive, whereas NMF was least effective. (See Table III.)
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Figure 3 Growth curves and creatine kinase activity of BA-
HAN-IC tumour cells after exposure to NMF. Each value re-
presents the mean ± standard deviation of five replicate experi-
ments. The creatine kinase activity is shown as a percentage of
the control. 48 h and 72 h after exposure to NMF, the creatine
kinase activity is significantly different from the control (P< 0.05;
Wilcoxon test for unpaired samples). The difference between the
growth curves is statistically significant (P<0.001; analysis of
variance with two independent factors). ck, creatine kinase
activity; tD, mean doubling time; ncontrol, cell number in standard
growth medium; nNMF, cell number in growth medium supp-
lemented with NMF.
Discussion
The present study clearly demonstrates that DMSO, HMBA,
NaBut and NMF are effective inducers of differentiation in
our rhabdomyosarcoma cell line BA-HAN-IC, simultaneous-
ly inhibiting tumour cell proliferation. Nevertheless, the
response of BA-HAN-IC tumour cells was markedly hetero-
geneous between the different polar compounds, probably
indicating different mechanisms of action and signal trans-
duction. Thus, the effects were most pronounced after
exposure to NMF as evidenced by an increase in both
biochemical and morphological differentiation and a
significant increase in the proportion of terminally
differentiated postmitotic myotube-like giant cells. In
contrast, the effects of DMSO, HMBA and NaBut were
exclusively confined to an increase in creatine kinase activity
used as a biochemical marker of differentiation, whereas no
increase in morphological differentiation was observed and
the formation of terminally differentiated postmitotic
mytotube-like giant cells even significantly decreased. A cor-
responding inhibition of myotube formation had already
been reported for non-tumorigenic myoblast cell lines after
exposure to DMSO, HMBA and NaBut (Miranda et al.,
1978; Blau & Epstein, 1979; Fiszman et al., 1980; Endo &
Nadal-Ginard, 1987). DMSO, HMBA and NaBut exhibited
rather contradictory properties in our rhabdomyosarcoma
cell line, inducing biochemical differentiation on the one
hand and simultaneously inhibiting cell fusion and terminal
differentiation on the other hand. These observations suggest
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Figure 4 Growth curves and creatine kinase activity of BA-
HAN-IC tumour cells after exposure to HMBA. Each value
represents the mean ± standard deviation of five replicate experi-
ments. The creatine kinase activity is shown as a percentage of
the control. 48 h, 72 h and 96 h after exposure to HMBA, the
creatine kinase activity is significantly different from the control
(P<0.05; Wilcoxon test for unpaired samples). The difference
between the growth curves is statistically significant (P<0.001;
analysis of variance with two independent factors). ck, creatine
kinase activity; tD, mean doubling time; n<Ontr.1, cell number in
standard growth medium; nHMBA, cell number in growth medium
supplemented with HMBA.
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Figure 5 Growth curves and creatine kinase activity of BA-
HAN-IC tumour cells after exposure to NaBut. Each value
represents the mean ± standard deviation of five replicate
experiments. The creatine activity is shown as a percentage of the
control. Between 24 and 120 h after exposure to NaBut, the
creatine kinase activity is significantly different from the control
(P<0.05; Wilcoxon test for unpaired samples). The difference
between the growth curves is statistically significant (P<0.001;
analysis of variance with two independent factors). ck, creatine
kinase activity; tD, mean doubling time; n.,ntrohI cell number in
standard growth medium; nN.Bul, cell number in growth medium
supplemented with NaBut.
Table II Fusion assay of BA-HAN-IC tumour cells after exposure to polar com-
pounds
Number ofmyotube-like Rat Number ofmyotube-like giant cells*
giant cells* atio total number ofcells
Initially After 120 h Initially After 120 h
Control 2.4 1.5 277 64 8x 10-6± 5 x 10-6 15x 10-6+ 4x 10-6
DMSO 3.4 1.5 23 20 x 106+ 5x10-6 7 x10-6 5 x10-6
HMBA 3.6±2.5 6± 5 12 x 10-6+ 8 x 10-6 8 x 10-7+ 6x 10-7
NaBut 6.0 3.5 5± 4 20x 10-6±11 x 10-6 8 x 10-7± 5x 10-7
NMF 1.8 0.8 959±363 6x 10-6± 3 x 10-6 83 x 10-6±33 x 10-6
Each value represents the mean ± standard deviation of five replicate experiments.
After 120 h theratio between thenumberofmyotube-likegiantcells and the total number
of cells is significantly different from the initial ratio for all experimental groups
(P<0.001; analysis ofvariance with two independent factors; repeated measurements in
one factor, i.e. time). * In 1/32 the growth area of the culture flask.
that the induction of biochemical differentiation by these
differentiation inducers might be regulated independently
from events leading to cell fusion and terminal
differentiation. The mechanisms, however, by which polar
compounds modulate cellular differentiation have not as yet
been conclusively defined. NaBut has been shown to alter
gene transcription by hyperacetylation of histones (Candido
Table III Plating efficiency of BA-HAN-IC tumour cells as a percen-
tage of the control after exposure to polar compounds
Number ofcells Plating efficiency (% ofthe control)
seededper microwell DMSO HMBA NaBut NMF
10 98% 4% 91% 99%
1 53% 2% 27% 82%DIFFERENTIATION INDUCTION WITH POLAR COMPOUNDS 583
et al., 1978) or by interfering with DNA methylation (Christ-
man et al., 1980). Nevertheless, it is not yet known whether
all the polar compounds exclusively act at the nuclear site
altering gene transcription or epigenetically affect other cel-
lular functions and structures such as glutathione metabolism
(Bill et al., 1988) or cell membranes (Blau & Epstein, 1979;
Meilhoc et al., 1986). Therefore, differentiation inducers such
as DMSO, HMBA and NaBut that induce biochemical
differentiation, but block the formation of terminally
differentiated myotube-like giant cells, could become useful
tools in further elucidating the mechanisms involved in
differentiation induction by polar compounds.
It is important to note that induction of biochemical differ-
entiation during the first 48 h was always accompanied by a
statistically significant inhibition of tumour cell proliferation.
However, the acceleration of proliferation beginning 48 h
after exposure to polar compounds (Figures 2-5) was ac-
companied by a marked decrease of biochemical differen-
tiation as indicated by the decline of the creatine kinase
activity. The way in which proliferation and differentiation
interact with each other, however, is still poorly understood.
Interestingly in this context, cells of our rhabdomyosarcoma
cell line BA-HAN-IC could also be induced to differentiate
only by exposure to FCS-depleted medium that did not
support cell proliferation (Gerharz et al., 1989). These obser-
vations might suggest a genetic programme interacting be-
tween proliferation and differentiation of tumour cells, which
is similar to that proposed for normal cells (Harris et al.,
1986; Sachs, 1987). This view is further supported by recent
reports on the involvement of protooncogene expression in
differentiation induction (Craig et al., 1984; Amatruda et al.,
1985; Thiele et al., 1985; Mulder & Brattain, 1988). In our own
investigations, we could demonstrate that the protooncogenes
fos and raf are implicated in the process of differentiation
induction in our rhabdomyosarcoma cell line BA-HAN-IC
after exposure to retinoic acid (Doehmer et al., 1989). Further
studies on biochemical and genetic levels are therefore in
progress that should bring more insights into the regulatory
events taking place in BA-HAN-IC tumour cells during
differentiation induction by different types of differentiation
inducers.
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